Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 40 composition records across product categories including Laboratory supplies, Cleaning and safety, Personal care.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of TRIBASIC CALCIUM PHOSPHATE in our catalog (fda_ndc).
Products
264
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside TRIBASIC CALCIUM PHOSPHATE in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 40 composition records across product categories including Laboratory supplies, Cleaning and safety, Personal care. EPA CPDat classifies this chemical for functional uses including Filler, Abrasive, Oral Care Agent.
US
FDA
Max protein daily choco almond bar
Ritebite
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 176 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 32.73 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 330 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 130 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 40 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 333.3 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 750 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 21.8 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 99.2 mg
US
FDA
FDA NDC lists this ingredient in 236 active drug products and 264 total products.